Beyond Use Date of Rifampicin Pulverized and Its Influencing Factors
DOI:
https://doi.org/10.24071/jpsc.v23i1.1083Keywords:
Beyond use date, High performance liquid Chromatography, rifampicin pulverized, tuberculosis (Cambria, 10 pt, alphabetically ordered)Abstract
Inaccurate drug dosage during Tuberculosis (TB) therapy is one of the factors causing TB resistance, especially for drugs that undergo a compounding process, which are often prescribed for children. Inappropriate storage of drugs during therapy can cause a reduction in drug content, which results in changes in drug dosage, therefore drugs should be used within a certain time limit or what is known as the Beyond Use Date (BUD). This study aims to determine the BUD in rifampicin powder preparations from a hospital in the Bogor district. Rifampicin powder preparations are packaged in 3 types of packaging (paper silk, parchment and capsules). Storage wascarried out at 2 temperatures, namely room temperature 25-28 °C and warm temperature 30-35 °C. Rifampicin levels were analyzed using High Performance Liquid Chromatography (HPLC). The results showed that the BUD of paper silk, parchment and capsule packaging at room temperature were 8, 11, and 14 days respectively, while storage at warm temperatures was 11, 10, and 12 days. This study stated that rifampicin powder preparations should be used for 7-13 days. Factors that affect BUD are the moisture content of the preparation, the container (type of packaging) and the storage conditions (temperature).
References
Acuña, L., Hamadat, S., Corbalán, N.S., González-lizárraga, F., Dos-santos-pereira, M., Rocca, J., Díaz, J.S., Del-bel, E., Papy-garcía, D., Chehín, R.N., Michel, P.P., Raisman-Vozari, R., 2019. Rifampicin and its derivative rifampicin quinone reduce microglial inflammatory responses and neurodegeneration induced in vitro by α-synuclein fibrillary aggregates. Cells, 8(8).
AOAC, 2016. Official Methods Of Analysis Of The Association of Analytical Chemist. Virginia.
Feinstein, J., Dai, D., Zhong, W., Freedman, J., Feudtner, C., 2015. Potential Drug−Drug Interactions in Infant, Child, and Adolescent Patients in Children’s Hospitals. Pediatrics, 135(1), e99–e108.
Harmita, H., 2004. PETUNJUK PELAKSANAAN VALIDASI METODE DAN CARA PERHITUNGANNYA. Majalah Ilmu Kefarmasian, 1(3), 117–135.
Liu, H., He, Z.-Z., Yu, L., Ma, J., Jin, X.-P., 2021. Improved solubility and stability of rifampicin as an inclusion complex of acyclic cucurbit[n]uril. Journal of Inclusion Phenomena and Macrocyclic Chemistry, 101(1–2), 111–120.
Ministry of Health of the Republic of Indonesia, 2020. Farmakope Indonesia, VI. ed. Kementrian Kesehatan RI, Jakarta.
Ministry of Health of the Republic of Indonesia, 2019. Laporan hasil riset Kesehatan dasar (Rikesdas) Indonesia Tahun 2018. Jakarta.
Mustafa, H., 2019. Paradigma Tenaga Teknis Kefarmasian (TTK) Tentang Beyond Use Date (BUD) Obat Dengan Memanfaatkan Media Sosial. Politeknik Kesehatan Kemenkes Kupang, Kupang.
Pyta, K., Przybylski, P., Klich, K., Stefańska, J., 2012. A new model of binding of rifampicin and its amino analogues as zwitterions to bacterial RNA polymerase. Organic & Biomolecular Chemistry, 10(41), 8283.
Rayfield, W.J., McKechnie, W.S., Kandula, S., 2021. Considerations for Implementation of a New Drug Substance Container for Subzero Storage. Journal of Pharmaceutical Sciences, 110(3), 1067–1076.
Ryoo, S., Jnawali, H.N., 2013. First– and Second–Line Drugs and Drug Resistance, in: Mahboub, B., Vats, M.G. (Eds.), Tuberculosis - Current Issues in Diagnosis and Management. IntechOpen, Rijeka.
Septiasari, A.P., 2018. Perhitungan Batas Waktu Penggunaan (Beyond Use Date) Sediaan Pulveres Dari Tablet Parasetamol Berbagai Merek (Skripsi). Universitas Gadjah Mada, Yogyakarta.
Siahaan, S., Mulyani, U.A., 2013. Praktik Peracikan Puyer untuk Anak Penderita Tuberkulosis di Indonesia. Kesmas: National Public Health Journal, 158.
USP, 2019. USP Compounding Standards and Beyond-Use Dates (BUDs) [WWW Document]. https://www.usp.org/sites/default/files/usp/document/our-work/compounding/usp-bud-factsheet.pdf.
World Health Organization, 2024. Global Tuberculosis Report 2024 [WWW Document]. https://www.who.int/teams/global-programme-on-tuberculosis-and-lung-health/tb-reports.
Yuneka Saristiana, Fendy Prasetyawan, Charliandri Saputra Wahab, Nanda Ardianto, Lily Aina, 2023. Uji Keseragaman Bobot Resep Racikan Terhadap Kualitas Serbuk Bagi (Pulveres) Paracetamol Pada Pasien Anak Di Apotek Khodijah Kabupaten Jombang Tahun 2022. Jurnal Inovasi Farmasi Indonesia, 4(2), 81–87.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Jurnal Farmasi Sains dan Komunitas (Journal of Pharmaceutical Sciences and Community)
This work is licensed under a Creative Commons Attribution 4.0 International License.
